<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04831021</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0462</org_study_id>
    <nct_id>NCT04831021</nct_id>
  </id_info>
  <brief_title>Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role?</brief_title>
  <acronym>EXP DIAL</acronym>
  <official_title>Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AIDER- Santé</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Avignon University (EA4278 - LaPEC)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prof Philippe OBERT</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr Claire MAUFRAIS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at evaluating, in chronic kidney disease patients on dialysis, the effect of&#xD;
      acute per- or pre-dialytic physical exercise on regional myocardial function and myocardial&#xD;
      stunning, blood viscosity, arterial stiffness, variability of sinus rhythm, dialysis&#xD;
      efficacy, inflammation, mineral and bone disorders, myokines and cardiac remodeling markers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All patients will be assigned to one dialysis session without physical exercise, one dialysis session with pre-dialytic physical exercise and one dialysis session with per-dialytic physical exercise in random order.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in regional myocardial function and myocardial stunning</measure>
    <time_frame>Weekly over a period of 3 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in blood viscosity</measure>
    <time_frame>Weekly over a period of 3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in arterial stiffness</measure>
    <time_frame>Weekly over a period of 3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in sinus rhythm</measure>
    <time_frame>Weekly over a period of 3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dialysis efficacy</measure>
    <time_frame>Weekly over a period of 3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in inflammatory markers</measure>
    <time_frame>Weekly over a period of 3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mineral and bone metabolism markers</measure>
    <time_frame>Weekly over a period of 3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in myokines</measure>
    <time_frame>Weekly over a period of 3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cardiac remodeling markers</measure>
    <time_frame>Weekly over a period of 3 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Chronic Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>Patients issued from dialysis units (clinic)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dialysis without physical exercise</intervention_name>
    <description>Hemodialysis control condition</description>
    <arm_group_label>Patients issued from dialysis units (clinic)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dialysis with pre-dialytic physical exercise</intervention_name>
    <description>Patients will pedal for 30 minutes using a ergometer directly attached to the dialysis bed. The exercise will be performed 60 minutes before connection to hemodialysis.</description>
    <arm_group_label>Patients issued from dialysis units (clinic)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dialysis with per-dialytic physical exercise</intervention_name>
    <description>Patients will pedal for 30 minutes using a ergometer directly attached to the dialysis bed. The exercise will start 30 minutes after the start of dialysis.</description>
    <arm_group_label>Patients issued from dialysis units (clinic)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged ≥ 20 to ≤ 79 years&#xD;
&#xD;
          -  Undernourished patient according to the ARNOS score : 2 and 3&#xD;
&#xD;
          -  No medical contraindication to physical activity&#xD;
&#xD;
          -  Life expectancy greater than 6 months&#xD;
&#xD;
          -  Patient on hemodialysis for more than 3 months&#xD;
&#xD;
          -  Patients with relatively good echogenicity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant, parturient or breastfeeding patient&#xD;
&#xD;
          -  Patient with a contraindication to retraining&#xD;
&#xD;
          -  Patient with valvular heart disease, arteriopathy of the lower limbs stage III and IV,&#xD;
             amputation or knee or hip prosthesis&#xD;
&#xD;
          -  Patient with musculoskeletal problems&#xD;
&#xD;
          -  Patient with severe respiratory failure&#xD;
&#xD;
          -  Paired sleep apnea syndrome&#xD;
&#xD;
          -  BMI&gt; 35&#xD;
&#xD;
          -  Patient with a pacemaker, cardiac stimulation and automatic implantable defibrillator&#xD;
&#xD;
          -  Heart transplant&#xD;
&#xD;
          -  Uncontrolled high blood pressure&#xD;
&#xD;
          -  Ejection fraction &lt;45%&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Paul CRISTOL, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Lapeyronie, Department of Biochemistry and Hormonology, Montpellier, FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>François ROUBILLE, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU ADV, Department of Cardiology, Montpellier, FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cécile TURC-BARON, MD</last_name>
    <role>Study Chair</role>
    <affiliation>AIDER Santé, Montpellier, FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jérôme ADDA, MD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU ADV, Department of Cardiology, Montpellier, FRANCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean Paul CRISTOL, MD, PhD</last_name>
    <phone>04 67 33 83 14</phone>
    <email>jp-cristol@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lapeyronie Hospital clinical trials Department</name>
      <address>
        <city>Montpellier</city>
        <state>Hérault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jean Paul CRISTOL, MD, PhD</last_name>
      <phone>04 67 33 83 14</phone>
      <email>jp-cristol@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 1, 2021</study_first_submitted>
  <study_first_submitted_qc>April 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic kidney disease on dialysis</keyword>
  <keyword>Physical exercise</keyword>
  <keyword>Regional myocardial function</keyword>
  <keyword>Myocardial stunning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

